Literature DB >> 8244134

Gastric metaplasia and Helicobacter pylori infection.

L A Noach1, T M Rolf, N B Bosma, M P Schwartz, J Oosting, E A Rauws, G N Tytgat.   

Abstract

Duodenal and antral mucosal biopsy specimens were obtained from 139 patients with dyspeptic complaints to study the prevalence and extent of gastric metaplasia in the duodenal bulb in relation to Helicobacter pylori (H pylori) infection and duodenal ulcer disease. On logistic regression, the presence and extent of gastric metaplasia was not significantly associated with H pylori infection. The prevalence of gastric metaplasia, however, was found to be higher in patients with current or past evidence of duodenal ulcer disease in comparison with subjects with functional dyspepsia (p = 0.01). A follow up study on 22 patients before and at least one year after eradication of H pylori showed that the mean extent of gastric metaplasia did not change significantly after eradication and did not differ when compared with 21 patients with persisting infection. It is concluded that the unchanged gastric acid output after eradication of H pylori is a more important factor in the development of gastric metaplasia than the H pylori related inflammatory process.

Entities:  

Mesh:

Year:  1993        PMID: 8244134      PMCID: PMC1374412          DOI: 10.1136/gut.34.11.1510

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  EXPERMENTAL PRODUCTION OF GASTRIC EPITHELIUM IN THE DUODENUM.

Authors:  J RHODES
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

2.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

3.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

4.  Gastric metaplasia of the duodenal bulb--a prospective endoscopic study.

Authors:  V Terruzzi; G Minoli; G Butti; G Imperiali
Journal:  Endoscopy       Date:  1987-11       Impact factor: 10.093

5.  Attempt to fulfil Koch's postulates for pyloric Campylobacter.

Authors:  B J Marshall; J A Armstrong; D B McGechie; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738

6.  Campylobacter pylori and development of duodenal ulcer.

Authors:  J I Wyatt; B J Rathbone; M F Dixon; R V Heatley; A T Axon
Journal:  Lancet       Date:  1988-01-16       Impact factor: 79.321

7.  Prevalence of gastric metaplasia, inflammation, and Campylobacter pylori in the duodenum of members of a normal population.

Authors:  P L Fitzgibbons; C P Dooley; H Cohen; M D Appleman
Journal:  Am J Clin Pathol       Date:  1988-12       Impact factor: 2.493

8.  A study of incidence and relationship of intestinal metaplasia of gastric antrum and gastric metaplasia of duodenum in patients with nonulcer dyspepsia.

Authors:  S Shousha; I G Barrison; W El-Sayeed; S Khan; R A Parkins
Journal:  Dig Dis Sci       Date:  1984-04       Impact factor: 3.199

9.  Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis.

Authors:  J I Wyatt; B J Rathbone; M F Dixon; R V Heatley
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

10.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

View more
  8 in total

1.  Mechanisms involved in Helicobacter pylori induced duodenal ulcer disease:an overview.

Authors:  Lars Olbe; Lars Fandriks; Annika Hamlet; Ann-Mari Svennerholm; Ann-Catrin Thoreson
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Gastric metaplasia and Helicobacter pylori infection.

Authors:  V Savarino; G S Mela; G Celle; S Vigneri
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

3.  Eradication of Helicobacter pylori in management of peptic ulceration. Gastric metaplasia should be considered too.

Authors:  F I Tovey
Journal:  BMJ       Date:  1995-02-25

4.  Effect of Helicobacter pylori eradication on 24-hour gastric pH and duodenal gastric metaplasia.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; G Bisso; M Pivari; C Mansi; L Tessieri; G Lapertosa; P Ceppa; S Vigneri
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

5.  Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; L Lapertosa; R Patetta; E Dallorto; A Vassallo; C Mansi; S Vigneri; G Celle
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

6.  Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb.

Authors:  A W Harris; P A Gummett; M M Walker; J J Misiewicz; J H Baron
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

7.  Omeprazole promotes proximal duodenal mucosal bicarbonate secretion in humans.

Authors:  A Mertz-Nielsen; J Hillingsø; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

8.  Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum.

Authors:  S Khulusi; M A Mendall; S Badve; P Patel; C Finlayson; T C Northfield
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.